Our team has published 14 peer-reviewed papers across the world's top AI and computational biology venues, including 1 oral presentation at AAAI-26 in Singapore.
Reversed amyloid plaque accumulation, resolved tau tangles, repaired blood-brain barrier, and restored cognitive function in the most aggressive Alzheimer's mouse model. This landmark paper demonstrates the multi-target therapeutic potential of NAD+ pathway activation via P7C3-A20.
1 oral presentation, 3 poster sessions, and 1 workshop at the 40th AAAI Conference on Artificial Intelligence in Singapore.
Peer-reviewed publications across NeurIPS, ICML, ICLR, ISMB, IEEE, and leading AI symposia.
We're actively seeking research partnerships with Alzheimer's foundations, academic labs, and clinical research organizations.